Skip to content

P-21

PeptidespeptideEarly stage

Availability Not yet tested in people

What it is

P-21, also written P021, is a short synthetic peptide cut from the active region of ciliary neurotrophic factor and modified with an adamantane group so it crosses the blood-brain barrier and resists breakdown. It was designed by Khalid Iqbal's laboratory at the New York State Institute for Basic Research as a neurotrophic compound for Alzheimer's disease and related tauopathies.

Why people take it

It is sold as the neurogenesis peptide, a way to grow new hippocampal neurons and raise BDNF rather than borrow attention from a stimulant. Interest tends to come from people watching memory slip, carrying a family history of dementia, or looking for something that acts on the structure of the brain rather than its chemistry for a day.

How it's delivered

Injection or nasal preparations, offered on a small number of clinic peptide menus. No regulator has approved P-21 for anything, and there is no established human dose, because no dose has ever been published in people. What circulates is laboratory material, with identity and purity unverified.

Where the evidence stands

The preclinical work is genuine and reasonably deep. In mouse models of Alzheimer's disease and tauopathy, chronic P-21 treatment increased dentate gyrus neurogenesis, raised BDNF, reduced tau hyperphosphorylation, and prevented dendritic and synaptic deficits alongside cognitive impairment. Every one of those results is in rodents. There is no published human trial of any phase, which means no pharmacokinetics, no safety profile, no dose-response, and no efficacy signal in people. The gap between a promising mouse compound and a working human drug is where most of this field's failures live.

Estimated cost

  • No approved or lawfully compounded product, so no reference price
  • Not covered by insurance

Who offers it

We don't list providers for P21: there is no approved product and no lawful compounding route, so there is nothing we can point you to. Anything sold online is unregulated.

Go deeper

No cognitive peptides guide yet. The Peptide Explorer entry carries the compound record, and the peptide therapy hub covers what a compound needs to show before mouse results mean anything for a person.

P-21 in the Peptide Explorer · Peptide Therapy for Longevity

Longevity.io is for educational purposes only and is not medical advice. We list P-21 so the evidence record is clear, not because a compound never tested in humans belongs on a price list. Confirm eligibility, product source, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint